Filter
361
Text search:
Plasmodium
falciparum
Featured
Recommendations
35
New Publications
158
Language
Document type
No document type
224
Guidelines
53
Studies & Reports
45
Manuals
16
Training Material
11
Strategic & Response Plan
8
Fact sheets
3
Situation Updates
1
Countries / Regions
India
19
Global
18
Senegal
16
Mozambique
12
Burkina Faso
11
Sierra Leone
11
Uganda
11
Ethiopia
9
Africa
9
Congo, Democratic Republic of
8
Tanzania
8
Myanmar / Burma
8
Liberia
7
Ghana
7
Zambia
7
Kenya
7
Latin America and the Carribbean
7
Venezuela
7
Nigeria
6
Cameroon
6
Nepal
6
Malawi
6
Cambodia
5
Bangladesh
5
South Africa
4
Brazil
4
Botswana
4
Angola
4
Madagascar
4
Zimbabwe
3
Philippines
3
Indonesia
3
Guinea
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
Colombia
2
Haiti
1
Somalia
1
South Sudan
1
Afghanistan
1
Lebanon
1
Thailand
1
Rwanda
1
Papua New Guinea
1
Argentina
1
Peru
1
North Macedonia
1
Burundi
1
Bolivia
1
Chile
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western and Central Europe
1
Asia
1
Southern Africa
1
Laos
1
Russia
1
Iran
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
195
Clinical Guidelines
61
Public Health
35
Pharmacy & Technologies
24
Women & Child Health
19
Key Resources
7
Capacity Building
5
Toolboxes
NTDs
16
Pharmacy
13
Planetary Health
9
HIV
8
AMR
7
COVID-19
7
Health Financing Toolbox
6
Caregiver
5
Rapid Response
4
Zika
4
Global Health Education
4
Conflict
2
Mental Health
2
Ebola
1
Natural Hazards
1
Refugee
1
Specific Hazards
1
NCDs
1
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t
...
La néphrologie pédiatrique (NP) a connu ces dernières années des progrès impressionnants en matière de soins. Cependant, le plus grand défi dans notre continent africain est de fournir aux enfants atteints de maladie rénale l’accès à une prise en
charge spécialisée par des néphrologu
...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina
...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
The sub-Saharan African region, carries 90% of the over 250 million cases of schistosomiasis occurring worldwide. In this region, after Nigeria, Tanzania is second country having the highest cases of schistosomiasis and approximately 51.5%0 of the Tanzanian population is either exposed or live in ar
...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou
...
O objetivo desta nota conceitual e a estrutura que essa descreve tratam da eliminação de um grupo de DT e abordam os efeitos negativos para a saúde que essas DT causam (as doenças constam da Tabela 1 abaixo), e que, juntos, criam uma carga tangível sobre os indivíduos afetados, suas famílias,
...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp
...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth
...
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u
...
This results report for the biennium 2020–2021 presents the progress towards the triple billion targets, outcomes and outputs, based on the GPW 13 results framework and indicators. It uses structured methodologies, both quantitative and qualitative, for measuring and analysing the achievements and
...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he
...
MOBILISIERUNG INLÄNDISCHER ÖFFENTLICHER RESSOURCEN FÜR GESUNDHEIT
Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assistance for health. This year’s updated estimates show that despite lackluster economic growth and fi
...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa
...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra
...
Background book on Management of the Child with a Serious Infection or Severe Malnutrition
Guidelines for malaria vector control
recommended
these guidelines are updated on 16 February 2021
Please check the new guideline here
https://medbox.org/document/who-guidelines-for-malaria#GO
